A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely Psychotic Patients With Schizophrenia
Status:
Recruiting
Trial end date:
2021-06-01
Target enrollment:
Participant gender:
Summary
This is a study designed to evaluate the efficacy and safety of lurasidone in acutely
psychotic patients with chronic schizophrenia and to confirm the non-inferiority of
lurasidone relative to quetiapine XR.